Corneal implants Market By Procedure Type (Penetrating keratoplasty, Endothelial keratoplasty, Others), By Disease Type (Keratoconus, Fuchs' dystrophy, Infectious keratitis, Others), By End User (Hospitals, Ophthalmic centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Corneal implants Market

The transparent front surface of the eye that protects the iris, pupil, and anterior chamber is called the cornea. In a cornea transplant, the diseased cornea is removed whole or partially and is replaced with healthy donor tissue or artificial cornea. The cornea, the clearest, outermost part of the eyeball's covering, protects the iris and pupil while permitting light to reach the interior. As light enters the eye, it concentrates and directs it. The cornea accounts for 65 to 75 percent of the eye's total focusing power. 

Key factors driving the growth of the corneal implant market include surge in prevalence of eye diseases such as fuchs’ dystrophy, keratoconus keratitis, corneal scarring, corneal ulcers and corneal edema. For an instance, according to the National Programme for Control of Blindness (NPCB) estimates, there are currently 120,000 corneal blind persons in the India. According to this estimate there is addition of 25,000-30,000 corneal blindness cases every year in the country. Thus, high prevalence of the corneal disorders along with corneal blindness across the globe propels the market growth. 

In addition, the availability of improved healthcare infrastructure and an increase in demand for corneal transplantation, the corneal implant market is anticipated to grow as a result of opportunities in undeveloped and emerging economies. In addition, the demand for improved advanced manufacturing systems and large government investments in enhancing healthcare infrastructure are both contributing to the significant growth of the healthcare sector in emerging nations. Furthermore, pharmaceutical companies are focused in emerging economies like China and India, which are predicted to offer attractive potential for the growth of the global market throughout the forecast period. 

Moreover, there have been several technological advancements in corneal implant surgery in recent years that have improved the safety and effectiveness of the procedure. For an instance, The CorNeat KPro implant is a patented synthetic cornea utilizing advanced cell technology to integrate artificial optics within resident ocular tissue. It is produced using nanoscale chemical engineering, which stimulates cellular growth. This further propels key manufacturers to introduce advanced and novel artificial cornea in the market. Thus, introduction of such advanced technologies are expected to propel the market growth during the forecast period. 

However, shortage of donor cornea is anticipated to restrain the market growth. The less availability of the donor corneas in many parts of the world, which can make it difficult for people who need corneal transplants to receive them. Conversely, sncrease in geriatric population is a lucrative opportunity for the global corneal implant market. Geriatric population is majorly susceptible to suffer from eye diseases such as dry eye, fuchs’ dystrophy, age-related macular degeneration, and fungal keratitis. In addition, owing to the process of aging, nerves and muscles surrounding eyes become weak and the optic nerve is unable to withstand various affronts, which further increase the eye pressure. Moreover, according to the World Health organization (WHO), by 2030, 1 in 6 people in the world will be aged 60 years or over. Thus rise in geriatric population offers a opportunity for the corneal implant market growth during the forecast period. 

The corneal implants market is segmented into procedure type, disease type, end user and region. By procedure type, the market is categorized into penetrating keratoplasty, endothelial keratoplasty and others. By disease type, the market is segregated into keratoconus, fuchs’ dystrophy, infecticous keratitis and others. By end user, the market is categorized into hospitals, ophthalmic centers and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).   

The key players profiled in the study include Corneagen, Presbia Plc, Presbia Plc, mediphacos, Aurolab, AJL Opthalmic SA, LinkoCare Life Sciences AB, DIOPTEX, EyeYon Medical, and KeraMed, Inc.  

 

Key Market Insights:

By procedure type the penetrating keratoplasty segment was highest contributor to the market in 2021. However others segment is anticipated to register the highest CAGR during the forecast period.  

By disease type, the Fuchs’ dystrophy segment dominated the market in 2021, with the highest CAGR during the forecast period.   

Based on end user, the hospital segment was the largest revenue contributor to the market in 2021 and is estimated to reach $ 944.28 million by 2031. Whereas others segment is expected to register the highest CAGR of 5.6% during the forecast period 

Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. 

Overview

The global corneal implant market was valued at $1,264.18 million in 2021, and is projected to reach $2,124.44 million by 2031, registering a CAGR of 5.3% from 2022 to 2031.   

The outermost translucent portion of the eyeball's covering known as the cornea protects the iris and pupil while allowing light to enter the interior. It directs and concentrates light as it enters the eye. Between 65 and 75 percent of the eye's entire focusing power comes from the cornea.  

A corneal transplant involves replacing a cloudy cornea with a clear donor cornea. Donor tissue comes from individuals who have donated their eyes for the benefit of others. The donor corneas used in transplants are kept freshly stored in eye banks. Furthermore, artificial cornea is an option for transplant patients who cannot tolerate a human donor cornea. In order to correct vision issues caused by various ocular disorders, corneal transplants are typically performed.   

The global corneal implant market is expected to witness a substantial growth in the future, owing to surge in prevalence of eye diseases such as Fuchs’ dystrophy, keratoconus keratitis, corneal scarring, corneal ulcers and corneal edema. People suffering from these ocular diseases need corneal transplantation on the basis of severity of diseases.  

Furthermore, rise in incidences of corneal blindness is the primary factor that drives the growth of the cornea implant market. For instance, according to the SightLife organization more than 12.7 million people globally suffer from corneal blindness. Thus, rise in incidences of corneal blindness is the primary factor that drives the growth of the cornea implant market.  In addition, increase in incidences of trauma cases lead to high chances of eye injury, which further propel the market growth.   

Moreover, technological advancements in the development of the artificial cornea propel the market growth. Various key market players are involved in the development of the bioengineered artificial corneal implant which further drives the demand of the corneal implants subsequently flourish the market growth.  

Furthermore, growth opportunities in emerging markets contribute towards the growth of the market. Availability of improved healthcare industry infrastructure, growth in number of pharmaceutical industries, and surge in incidence of the corneal disorders drives the growth of the market in emerging economies. However, low availability of human cornea donors and high risk in the grafting artificial cornea implant is expected to impede the market growth during the forecast period. Conversely, rise in geriatric population is a lucrative opportunity for the market growth. As the geriatric population is more susceptible to corneal diseases.   

The global corneal implant market is segmented into type, disease type, transplant type, end user, and region. On the basis of disease type, the market is segregated into keratoconus, Fuchs’ dystrophy, infectious keratitis and others. On the basis of transplant type, market is segmented into penetrating keratoplasty, anterior lamellar keratoplasty, endothelial keratoplasty and keratoprothesis. On the basis of end user, the market is categorized into hospitals, ambulatory surgical centers and ophthalmic centers. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).  

Major Key players that operate in the global corneal implant market are Corneagen, Presbia Plc, Presbia Plc, mediphacos, Aurolab, AJL Opthalmic SA, LinkoCare Life Sciences AB, DIOPTEX, EyeYon Medical, and KeraMed, Inc. 

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the corneal implants market analysis from 2021 to 2031 to identify the prevailing corneal implants market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the corneal implants market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global corneal implants market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ KeraMed, In

Scope of Corneal implants Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of suppliers

3.3.2. Bargaining power of buyers

3.3.3. Threat of substitutes

3.3.4. Threat of new entrants

3.3.5. Intensity of rivalry

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in prevalence of corneal disorders

3.4.1.2. High growth potential in emerging markets

3.4.1.3. Technological advancements in the field of cornea

3.4.2. Restraints

3.4.2.1. Shortage of corneal donors

3.4.3. Opportunities

3.4.3.1. Increase in geriatric population

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Penetrating keratoplasty

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Endothelial keratoplasty

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Others

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Keratoconus

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Fuchs' dystrophy

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Infectious keratitis

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

5.5. Others

5.5.1. Key market trends, growth factors and opportunities

5.5.2. Market size and forecast, by region

5.5.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Ophthalmic centers

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

6.4. Others

6.4.1. Key market trends, growth factors and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast By Region

7.2. North America

7.2.1. Key trends and opportunities

7.2.2. Market size and forecast, by Procedure Type

7.2.3. Market size and forecast, by Disease Type

7.2.4. Market size and forecast, by End User

7.2.5. Market size and forecast, by country

7.2.5.1. U.S.

7.2.5.1.1. Key market trends, growth factors and opportunities

7.2.5.1.2. Market size and forecast, by Procedure Type

7.2.5.1.3. Market size and forecast, by Disease Type

7.2.5.1.4. Market size and forecast, by End User

7.2.5.2. Canada

7.2.5.2.1. Key market trends, growth factors and opportunities

7.2.5.2.2. Market size and forecast, by Procedure Type

7.2.5.2.3. Market size and forecast, by Disease Type

7.2.5.2.4. Market size and forecast, by End User

7.2.5.3. Mexico

7.2.5.3.1. Key market trends, growth factors and opportunities

7.2.5.3.2. Market size and forecast, by Procedure Type

7.2.5.3.3. Market size and forecast, by Disease Type

7.2.5.3.4. Market size and forecast, by End User

7.3. Europe

7.3.1. Key trends and opportunities

7.3.2. Market size and forecast, by Procedure Type

7.3.3. Market size and forecast, by Disease Type

7.3.4. Market size and forecast, by End User

7.3.5. Market size and forecast, by country

7.3.5.1. Germany

7.3.5.1.1. Key market trends, growth factors and opportunities

7.3.5.1.2. Market size and forecast, by Procedure Type

7.3.5.1.3. Market size and forecast, by Disease Type

7.3.5.1.4. Market size and forecast, by End User

7.3.5.2. France

7.3.5.2.1. Key market trends, growth factors and opportunities

7.3.5.2.2. Market size and forecast, by Procedure Type

7.3.5.2.3. Market size and forecast, by Disease Type

7.3.5.2.4. Market size and forecast, by End User

7.3.5.3. UK

7.3.5.3.1. Key market trends, growth factors and opportunities

7.3.5.3.2. Market size and forecast, by Procedure Type

7.3.5.3.3. Market size and forecast, by Disease Type

7.3.5.3.4. Market size and forecast, by End User

7.3.5.4. Italy

7.3.5.4.1. Key market trends, growth factors and opportunities

7.3.5.4.2. Market size and forecast, by Procedure Type

7.3.5.4.3. Market size and forecast, by Disease Type

7.3.5.4.4. Market size and forecast, by End User

7.3.5.5. Spain

7.3.5.5.1. Key market trends, growth factors and opportunities

7.3.5.5.2. Market size and forecast, by Procedure Type

7.3.5.5.3. Market size and forecast, by Disease Type

7.3.5.5.4. Market size and forecast, by End User

7.3.5.6. Rest of Europe

7.3.5.6.1. Key market trends, growth factors and opportunities

7.3.5.6.2. Market size and forecast, by Procedure Type

7.3.5.6.3. Market size and forecast, by Disease Type

7.3.5.6.4. Market size and forecast, by End User

7.4. Asia-Pacific

7.4.1. Key trends and opportunities

7.4.2. Market size and forecast, by Procedure Type

7.4.3. Market size and forecast, by Disease Type

7.4.4. Market size and forecast, by End User

7.4.5. Market size and forecast, by country

7.4.5.1. Japan

7.4.5.1.1. Key market trends, growth factors and opportunities

7.4.5.1.2. Market size and forecast, by Procedure Type

7.4.5.1.3. Market size and forecast, by Disease Type

7.4.5.1.4. Market size and forecast, by End User

7.4.5.2. China

7.4.5.2.1. Key market trends, growth factors and opportunities

7.4.5.2.2. Market size and forecast, by Procedure Type

7.4.5.2.3. Market size and forecast, by Disease Type

7.4.5.2.4. Market size and forecast, by End User

7.4.5.3. India

7.4.5.3.1. Key market trends, growth factors and opportunities

7.4.5.3.2. Market size and forecast, by Procedure Type

7.4.5.3.3. Market size and forecast, by Disease Type

7.4.5.3.4. Market size and forecast, by End User

7.4.5.4. Australia

7.4.5.4.1. Key market trends, growth factors and opportunities

7.4.5.4.2. Market size and forecast, by Procedure Type

7.4.5.4.3. Market size and forecast, by Disease Type

7.4.5.4.4. Market size and forecast, by End User

7.4.5.5. South Korea

7.4.5.5.1. Key market trends, growth factors and opportunities

7.4.5.5.2. Market size and forecast, by Procedure Type

7.4.5.5.3. Market size and forecast, by Disease Type

7.4.5.5.4. Market size and forecast, by End User

7.4.5.6. Rest of Asia-Pacific

7.4.5.6.1. Key market trends, growth factors and opportunities

7.4.5.6.2. Market size and forecast, by Procedure Type

7.4.5.6.3. Market size and forecast, by Disease Type

7.4.5.6.4. Market size and forecast, by End User

7.5. LAMEA

7.5.1. Key trends and opportunities

7.5.2. Market size and forecast, by Procedure Type

7.5.3. Market size and forecast, by Disease Type

7.5.4. Market size and forecast, by End User

7.5.5. Market size and forecast, by country

7.5.5.1. Brazil

7.5.5.1.1. Key market trends, growth factors and opportunities

7.5.5.1.2. Market size and forecast, by Procedure Type

7.5.5.1.3. Market size and forecast, by Disease Type

7.5.5.1.4. Market size and forecast, by End User

7.5.5.2. Saudi Arabia

7.5.5.2.1. Key market trends, growth factors and opportunities

7.5.5.2.2. Market size and forecast, by Procedure Type

7.5.5.2.3. Market size and forecast, by Disease Type

7.5.5.2.4. Market size and forecast, by End User

7.5.5.3. South Africa

7.5.5.3.1. Key market trends, growth factors and opportunities

7.5.5.3.2. Market size and forecast, by Procedure Type

7.5.5.3.3. Market size and forecast, by Disease Type

7.5.5.3.4. Market size and forecast, by End User

7.5.5.4. Rest of LAMEA

7.5.5.4.1. Key market trends, growth factors and opportunities

7.5.5.4.2. Market size and forecast, by Procedure Type

7.5.5.4.3. Market size and forecast, by Disease Type

7.5.5.4.4. Market size and forecast, by End User

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Top player positioning, 2021

9.1. Aurolab

9.1.1. Company overview

9.1.2. Key Executives

9.1.3. Company snapshot

9.1.4. Operating business segments

9.1.5. Product portfolio

9.2. AJL Opthalmic SA

9.2.1. Company overview

9.2.2. Key Executives

9.2.3. Company snapshot

9.2.4. Operating business segments

9.2.5. Product portfolio

9.3. CorneaGen

9.3.1. Company overview

9.3.2. Key Executives

9.3.3. Company snapshot

9.3.4. Operating business segments

9.3.5. Product portfolio

9.4. KeraMed, Inc

9.4.1. Company overview

9.4.2. Key Executives

9.4.3. Company snapshot

9.4.4. Operating business segments

9.4.5. Product portfolio

9.5. Presbia Plc

9.5.1. Company overview

9.5.2. Key Executives

9.5.3. Company snapshot

9.5.4. Operating business segments

9.5.5. Product portfolio

9.6. CorNeat Vision

9.6.1. Company overview

9.6.2. Key Executives

9.6.3. Company snapshot

9.6.4. Operating business segments

9.6.5. Product portfolio

9.7. Mediphacos

9.7.1. Company overview

9.7.2. Key Executives

9.7.3. Company snapshot

9.7.4. Operating business segments

9.7.5. Product portfolio

9.8. LinkoCare Life Sciences AB

9.8.1. Company overview

9.8.2. Key Executives

9.8.3. Company snapshot

9.8.4. Operating business segments

9.8.5. Product portfolio

9.9. EyeYon Medical

9.9.1. Company overview

9.9.2. Key Executives

9.9.3. Company snapshot

9.9.4. Operating business segments

9.9.5. Product portfolio

9.10. DIOPTEX

9.10.1. Company overview

9.10.2. Key Executives

9.10.3. Company snapshot

9.10.4. Operating business segments

9.10.5. Product portfoli

LIST OF TABLES

TABLE 01. GLOBAL CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 02. CORNEAL IMPLANTS MARKET FOR PENETRATING KERATOPLASTY, BY REGION, 2021-2031 ($MILLION)

TABLE 03. CORNEAL IMPLANTS MARKET FOR ENDOTHELIAL KERATOPLASTY, BY REGION, 2021-2031 ($MILLION)

TABLE 04. CORNEAL IMPLANTS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 05. GLOBAL CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 06. CORNEAL IMPLANTS MARKET FOR KERATOCONUS, BY REGION, 2021-2031 ($MILLION)

TABLE 07. CORNEAL IMPLANTS MARKET FOR FUCHS' DYSTROPHY, BY REGION, 2021-2031 ($MILLION)

TABLE 08. CORNEAL IMPLANTS MARKET FOR INFECTIOUS KERATITIS, BY REGION, 2021-2031 ($MILLION)

TABLE 09. CORNEAL IMPLANTS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 10. GLOBAL CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 11. CORNEAL IMPLANTS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 12. CORNEAL IMPLANTS MARKET FOR OPHTHALMIC CENTERS, BY REGION, 2021-2031 ($MILLION)

TABLE 13. CORNEAL IMPLANTS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 14. CORNEAL IMPLANTS MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 15. NORTH AMERICA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 16. NORTH AMERICA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 17. NORTH AMERICA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 18. NORTH AMERICA CORNEAL IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 19. U.S. CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 20. U.S. CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 21. U.S. CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 22. CANADA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 23. CANADA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 24. CANADA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 25. MEXICO CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 26. MEXICO CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 27. MEXICO CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 28. EUROPE CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 29. EUROPE CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 30. EUROPE CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 31. EUROPE CORNEAL IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 32. GERMANY CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 33. GERMANY CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 34. GERMANY CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 35. FRANCE CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 36. FRANCE CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 37. FRANCE CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 38. UK CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 39. UK CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 40. UK CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 41. ITALY CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 42. ITALY CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 43. ITALY CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 44. SPAIN CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 45. SPAIN CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 46. SPAIN CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 47. REST OF EUROPE CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 48. REST OF EUROPE CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 49. REST OF EUROPE CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 50. ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 51. ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 52. ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 53. ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 54. JAPAN CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 55. JAPAN CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 56. JAPAN CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 57. CHINA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 58. CHINA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 59. CHINA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 60. INDIA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 61. INDIA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 62. INDIA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 63. AUSTRALIA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 64. AUSTRALIA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 65. AUSTRALIA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 66. SOUTH KOREA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 67. SOUTH KOREA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 68. SOUTH KOREA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 69. REST OF ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 70. REST OF ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 71. REST OF ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 72. LAMEA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 73. LAMEA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 74. LAMEA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 75. LAMEA CORNEAL IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 76. BRAZIL CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 77. BRAZIL CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 78. BRAZIL CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 79. SAUDI ARABIA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 80. SAUDI ARABIA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 81. SAUDI ARABIA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 82. SOUTH AFRICA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 83. SOUTH AFRICA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 84. SOUTH AFRICA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 85. REST OF LAMEA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)

TABLE 86. REST OF LAMEA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 87. REST OF LAMEA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 88. AUROLAB: KEY EXECUTIVES

TABLE 89. AUROLAB: COMPANY SNAPSHOT

TABLE 90. AUROLAB: PRODUCT SEGMENTS

TABLE 91. AUROLAB: PRODUCT PORTFOLIO

TABLE 92. AJL OPTHALMIC SA: KEY EXECUTIVES

TABLE 93. AJL OPTHALMIC SA: COMPANY SNAPSHOT

TABLE 94. AJL OPTHALMIC SA: PRODUCT SEGMENTS

TABLE 95. AJL OPTHALMIC SA: PRODUCT PORTFOLIO

TABLE 96. CORNEAGEN: KEY EXECUTIVES

TABLE 97. CORNEAGEN: COMPANY SNAPSHOT

TABLE 98. CORNEAGEN: PRODUCT SEGMENTS

TABLE 99. CORNEAGEN: PRODUCT PORTFOLIO

TABLE 100. KERAMED, INC: KEY EXECUTIVES

TABLE 101. KERAMED, INC: COMPANY SNAPSHOT

TABLE 102. KERAMED, INC: PRODUCT SEGMENTS

TABLE 103. KERAMED, INC: PRODUCT PORTFOLIO

TABLE 104. PRESBIA PLC: KEY EXECUTIVES

TABLE 105. PRESBIA PLC: COMPANY SNAPSHOT

TABLE 106. PRESBIA PLC: PRODUCT SEGMENTS

TABLE 107. PRESBIA PLC: PRODUCT PORTFOLIO

TABLE 108. CORNEAT VISION: KEY EXECUTIVES

TABLE 109. CORNEAT VISION: COMPANY SNAPSHOT

TABLE 110. CORNEAT VISION: PRODUCT SEGMENTS

TABLE 111. CORNEAT VISION: PRODUCT PORTFOLIO

TABLE 112. MEDIPHACOS: KEY EXECUTIVES

TABLE 113. MEDIPHACOS: COMPANY SNAPSHOT

TABLE 114. MEDIPHACOS: PRODUCT SEGMENTS

TABLE 115. MEDIPHACOS: PRODUCT PORTFOLIO

TABLE 116. LINKOCARE LIFE SCIENCES AB: KEY EXECUTIVES

TABLE 117. LINKOCARE LIFE SCIENCES AB: COMPANY SNAPSHOT

TABLE 118. LINKOCARE LIFE SCIENCES AB: PRODUCT SEGMENTS

TABLE 119. LINKOCARE LIFE SCIENCES AB: PRODUCT PORTFOLIO

TABLE 120. EYEYON MEDICAL: KEY EXECUTIVES

TABLE 121. EYEYON MEDICAL: COMPANY SNAPSHOT

TABLE 122. EYEYON MEDICAL: PRODUCT SEGMENTS

TABLE 123. EYEYON MEDICAL: PRODUCT PORTFOLIO

TABLE 124. DIOPTEX: KEY EXECUTIVES

TABLE 125. DIOPTEX: COMPANY SNAPSHOT

TABLE 126. DIOPTEX: PRODUCT SEGMENTS

TABLE 127. DIOPTEX: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. CORNEAL IMPLANTS MARKET, 2021-2031

FIGURE 02. SEGMENTATION OF CORNEAL IMPLANTS MARKET, 2021-2031

FIGURE 03. TOP INVESTMENT POCKETS IN CORNEAL IMPLANTS MARKET (2022-2031)

FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS

FIGURE 05. MODERATE BARGAINING POWER OF BUYERS

FIGURE 06. MODERATE THREAT OF SUBSTITUTES

FIGURE 07. HIGH THREAT OF NEW ENTRANTS

FIGURE 08. MODERATE INTENSITY OF RIVALRY

FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALCORNEAL IMPLANTS MARKET

FIGURE 10. CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR PENETRATING KERATOPLASTY, BY COUNTRY 2021 AND 2031(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR ENDOTHELIAL KERATOPLASTY, BY COUNTRY 2021 AND 2031(%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 14. CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR KERATOCONUS, BY COUNTRY 2021 AND 2031(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR FUCHS' DYSTROPHY, BY COUNTRY 2021 AND 2031(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR INFECTIOUS KERATITIS, BY COUNTRY 2021 AND 2031(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 19. CORNEAL IMPLANTS MARKET, BY END USER, 2021(%)

FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY 2021 AND 2031(%)

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR OPHTHALMIC CENTERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 22. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 23. CORNEAL IMPLANTS MARKET BY REGION, 2021

FIGURE 24. U.S. CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 25. CANADA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 26. MEXICO CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 27. GERMANY CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 28. FRANCE CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 29. UK CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 30. ITALY CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 31. SPAIN CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 32. REST OF EUROPE CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 33. JAPAN CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 34. CHINA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 35. INDIA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 36. AUSTRALIA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 37. SOUTH KOREA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 38. REST OF ASIA-PACIFIC CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 39. BRAZIL CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 40. SAUDI ARABIA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 41. SOUTH AFRICA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 42. REST OF LAMEA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)

FIGURE 43. TOP WINNING STRATEGIES, BY YEAR

FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 47. COMPETITIVE DASHBOARD

FIGURE 48. COMPETITIVE HEATMAP: CORNEAL IMPLANTS MARKET

FIGURE 49. TOP PLAYER POSITIONING, 202